Key facts
- This page summarizes Eugene Williams's Form 4 filing for ProMIS Neurosciences Inc. (PMN).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 06 Mar 2026, 07:28.
Eugene Williams - 05 Mar 2026 Form 4 Insider Report for ProMIS Neurosciences Inc. (PMN)
- Reporting relationship
- Director
- Issuer ticker
- PMN
- Reported as of
- 05 Mar 2026
- Net transaction value
- +$48,800
- SEC form
- 4
- Accepted by SEC
- 06 Mar 2026, 07:28:00 UTC
- Prior SEC filing
- 04 Mar 2026
- Next SEC filing
- 22 May 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Max A. Milbury, Attorney in Fact for Eugene Williams
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Eugene Williams filed Form 4 for ProMIS Neurosciences Inc. (PMN) on 06 Mar 2026.
Change
- Previous filing in this sequence was filed on 04 Mar 2026.
- Current net transaction value: +$48,800.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001927626
Primary reporting owner
Williams Eugene
- Relationship
- Director
- Address
- C/O PROMIS NEUROSCIENCES INC., SUITE 200, 1920 YONGE STREET, TORONTO, ONTARIO, CANADA
- Signature
- /s/ Max A. Milbury, Attorney in Fact for Eugene Williams
- Signature date
- 06 Mar 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
PMN
transaction
Common Shares
Purchase
- Transaction value
- $48,800
- Shares
- +2,000
- Change %
- +19%
- Price
- $24.40
- Shares after
- 12,397
- Date
- 05 Mar 2026
- Ownership
- Direct
* marks a reported price that did not pass the local price check.